Cargando…

Cosmetic outcome as rated by patients, doctors, nurses and BCCT.core software assessed over 5 years in a subset of patients in the TARGIT-A Trial

BACKGROUND: The purpose of this research was to assess agreement between four rating systems of cosmetic outcome measured in a subset of patients with early breast cancer participating in the randomised TARGIT-A trial. TARGIT-A compared risk-adapted single-dose intra-operative radiotherapy (TARGIT-I...

Descripción completa

Detalles Bibliográficos
Autores principales: Corica, Tammy, Nowak, Anna K., Saunders, Christobel M., Bulsara, Max K., Taylor, Mandy, Williams, Norman R., Keshtgar, Mohammed, Joseph, David J., Vaidya, Jayant S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899392/
https://www.ncbi.nlm.nih.gov/pubmed/29653541
http://dx.doi.org/10.1186/s13014-018-0998-x
_version_ 1783314267775172608
author Corica, Tammy
Nowak, Anna K.
Saunders, Christobel M.
Bulsara, Max K.
Taylor, Mandy
Williams, Norman R.
Keshtgar, Mohammed
Joseph, David J.
Vaidya, Jayant S.
author_facet Corica, Tammy
Nowak, Anna K.
Saunders, Christobel M.
Bulsara, Max K.
Taylor, Mandy
Williams, Norman R.
Keshtgar, Mohammed
Joseph, David J.
Vaidya, Jayant S.
author_sort Corica, Tammy
collection PubMed
description BACKGROUND: The purpose of this research was to assess agreement between four rating systems of cosmetic outcome measured in a subset of patients with early breast cancer participating in the randomised TARGIT-A trial. TARGIT-A compared risk-adapted single-dose intra-operative radiotherapy (TARGIT-IORT) to whole breast external beam radiotherapy (EBRT). METHODS: Patients, their Radiation Oncologist and Research Nurse completed a subjective cosmetic assessment questionnaire before radiotherapy and annually thereafter for five years. Objective data previously calculated by the validated BCCT.core software which utilizes digital photographs to score symmetry, colour and scar was also used. Agreement was assessed by the Kappa statistic and longitudinal changes were assessed by generalized estimating equations. RESULTS: Overall, an Excellent-Good (EG) cosmetic result was scored more often than a Fair-Poor (FP) result for both treatment groups across all time points, with patients who received TARGIT-IORT scoring EG more often than those who received EBRT however this was statistically significant at Year 5 only. There was modest agreement between the four rating systems with the highest Kappa score being moderate agreement which was between nurse and doctor scores at Year 1 with Kappa = 0.46 (p < 0.001), 95% CI (0.24, 0.68). CONCLUSION: Despite similar overall findings between treatment groups and rating systems, the inter-rater agreement was only modest. This suggests that the four rating systems utilized may not necessarily be used interchangeably and it is arguable that for an outcome such as cosmetic appearance, the patient’s point of view is the most important. TRIAL REGISTRATION: TARGIT-A ISRCTN34086741, Registered 21 July 2004, retrospectively registered. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13014-018-0998-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5899392
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58993922018-04-23 Cosmetic outcome as rated by patients, doctors, nurses and BCCT.core software assessed over 5 years in a subset of patients in the TARGIT-A Trial Corica, Tammy Nowak, Anna K. Saunders, Christobel M. Bulsara, Max K. Taylor, Mandy Williams, Norman R. Keshtgar, Mohammed Joseph, David J. Vaidya, Jayant S. Radiat Oncol Research BACKGROUND: The purpose of this research was to assess agreement between four rating systems of cosmetic outcome measured in a subset of patients with early breast cancer participating in the randomised TARGIT-A trial. TARGIT-A compared risk-adapted single-dose intra-operative radiotherapy (TARGIT-IORT) to whole breast external beam radiotherapy (EBRT). METHODS: Patients, their Radiation Oncologist and Research Nurse completed a subjective cosmetic assessment questionnaire before radiotherapy and annually thereafter for five years. Objective data previously calculated by the validated BCCT.core software which utilizes digital photographs to score symmetry, colour and scar was also used. Agreement was assessed by the Kappa statistic and longitudinal changes were assessed by generalized estimating equations. RESULTS: Overall, an Excellent-Good (EG) cosmetic result was scored more often than a Fair-Poor (FP) result for both treatment groups across all time points, with patients who received TARGIT-IORT scoring EG more often than those who received EBRT however this was statistically significant at Year 5 only. There was modest agreement between the four rating systems with the highest Kappa score being moderate agreement which was between nurse and doctor scores at Year 1 with Kappa = 0.46 (p < 0.001), 95% CI (0.24, 0.68). CONCLUSION: Despite similar overall findings between treatment groups and rating systems, the inter-rater agreement was only modest. This suggests that the four rating systems utilized may not necessarily be used interchangeably and it is arguable that for an outcome such as cosmetic appearance, the patient’s point of view is the most important. TRIAL REGISTRATION: TARGIT-A ISRCTN34086741, Registered 21 July 2004, retrospectively registered. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13014-018-0998-x) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-13 /pmc/articles/PMC5899392/ /pubmed/29653541 http://dx.doi.org/10.1186/s13014-018-0998-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Corica, Tammy
Nowak, Anna K.
Saunders, Christobel M.
Bulsara, Max K.
Taylor, Mandy
Williams, Norman R.
Keshtgar, Mohammed
Joseph, David J.
Vaidya, Jayant S.
Cosmetic outcome as rated by patients, doctors, nurses and BCCT.core software assessed over 5 years in a subset of patients in the TARGIT-A Trial
title Cosmetic outcome as rated by patients, doctors, nurses and BCCT.core software assessed over 5 years in a subset of patients in the TARGIT-A Trial
title_full Cosmetic outcome as rated by patients, doctors, nurses and BCCT.core software assessed over 5 years in a subset of patients in the TARGIT-A Trial
title_fullStr Cosmetic outcome as rated by patients, doctors, nurses and BCCT.core software assessed over 5 years in a subset of patients in the TARGIT-A Trial
title_full_unstemmed Cosmetic outcome as rated by patients, doctors, nurses and BCCT.core software assessed over 5 years in a subset of patients in the TARGIT-A Trial
title_short Cosmetic outcome as rated by patients, doctors, nurses and BCCT.core software assessed over 5 years in a subset of patients in the TARGIT-A Trial
title_sort cosmetic outcome as rated by patients, doctors, nurses and bcct.core software assessed over 5 years in a subset of patients in the targit-a trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899392/
https://www.ncbi.nlm.nih.gov/pubmed/29653541
http://dx.doi.org/10.1186/s13014-018-0998-x
work_keys_str_mv AT coricatammy cosmeticoutcomeasratedbypatientsdoctorsnursesandbcctcoresoftwareassessedover5yearsinasubsetofpatientsinthetargitatrial
AT nowakannak cosmeticoutcomeasratedbypatientsdoctorsnursesandbcctcoresoftwareassessedover5yearsinasubsetofpatientsinthetargitatrial
AT saunderschristobelm cosmeticoutcomeasratedbypatientsdoctorsnursesandbcctcoresoftwareassessedover5yearsinasubsetofpatientsinthetargitatrial
AT bulsaramaxk cosmeticoutcomeasratedbypatientsdoctorsnursesandbcctcoresoftwareassessedover5yearsinasubsetofpatientsinthetargitatrial
AT taylormandy cosmeticoutcomeasratedbypatientsdoctorsnursesandbcctcoresoftwareassessedover5yearsinasubsetofpatientsinthetargitatrial
AT williamsnormanr cosmeticoutcomeasratedbypatientsdoctorsnursesandbcctcoresoftwareassessedover5yearsinasubsetofpatientsinthetargitatrial
AT keshtgarmohammed cosmeticoutcomeasratedbypatientsdoctorsnursesandbcctcoresoftwareassessedover5yearsinasubsetofpatientsinthetargitatrial
AT josephdavidj cosmeticoutcomeasratedbypatientsdoctorsnursesandbcctcoresoftwareassessedover5yearsinasubsetofpatientsinthetargitatrial
AT vaidyajayants cosmeticoutcomeasratedbypatientsdoctorsnursesandbcctcoresoftwareassessedover5yearsinasubsetofpatientsinthetargitatrial